Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions (Front. Immunol., (2022), 13, 893648, 10.3389/fimmu.2022.893648)

Angela I. Schriek, Marlies M. van Haaren, Meliawati Poniman, Gillian Dekkers, Arthur E. H. Bentlage, Marloes Grobben, Gestur Vidarsson, Rogier W. Sanders, Theo Verrips, Teunis B. H. Geijtenbeek, Raimond Heukers, Neeltje A. Kootstra, Steven W. de Taeye, Marit J. van Gils

Research output: Contribution to journalComment/Letter to the editorAcademic

2 Citations (Scopus)

Abstract

In the published article, there was an error in the Funding statement. The funder was mentioned as AIDSfonds and Aids fonds instead of Aidsfonds. The correct Funding statement appears below. Funding This work was supported by HealthHolland/Aidsfonds: LSHM19101/P-44802, by HealthHolland/AMC: 2019-1167 and the AMC Fellowship from Amsterdam UMC received by MJG. ST is supported by Young investigator grant P-53301 Aidsfonds. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Original languageEnglish
Article number1091668
JournalFrontiers in immunology
Volume13
DOIs
Publication statusPublished - 22 Nov 2022

Keywords

  • Fc fusion
  • Fc-mediated effector functions
  • HIV-1
  • nanobodies
  • neutralization

Cite this